PDSB

NASDAQStock

PDS Biotechnology Corporation

$0.65-0.01 (-1.01%)

52-Week Range

$0.64

$1.79

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.17

Volume

136.3K

Avg Volume

329.2K

Performance

-3.84%

-28.80%

-43.62%

YTD

-21.51%

-46.83%

-90.14%

-88.02%

Price Chart

ETF Exposure

PDSB is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
TYNE	Direxion Nanotechnology ETF	1.99%	1,924	$17K	$1.3M	0.65%
IWC	iShares Micro-Cap ETF	0.01%	119,703	$82K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	586,163	$488K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	48	$55	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,748	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	8	$9	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	995,421	$829K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	5,235	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	451	$509	$1.29B	0.17%

About PDSB ETF Exposure

PDS Biotechnology Corporation (PDSB) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.65. Investors can gain exposure to PDSB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PDSB, sorted by portfolio weight.